A Phase 1, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of Ascending Doses of AZD4547 in Patients with Advanced Solid Tumor Malignancies
What is the purpose of this trial?
- 18 Years and older
- September 2011
- Last Updated:
- Study HIC#:
Clinicaltrials.gov ID: Yale7349468